Teriparatide Pen Injector [Forteo]
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background: Due to high cost and burden of osteoporosis, it is reasonable to focus on the reduction of fractures as the main goal…
SummaryThere is a strong impetus to prevent and treat osteoporosis to prevent fractures. $990 million dollars was spent on anti…
SummarySince approval by the U.S. Food and Drug Administration (FDA) in December 2002, teriparatide (recombinant 1-34 PTH; Forteo…